Tagungen und Workshops zum Thema Onkologie

Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.

Organisatoren können kostenlos ihre Konferenzankündigungen veröffentlichen.

ALLE LÄNDER

1.
 
17th World Conference on Lung Cancer 2016
ID
649368
Termin
04. Dez 2016 - 07. Dez 2016
Ort
Wien, Österreich
Zusammenfassung
The World Conference on Lung Cancer (WCLC) is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. More than 7,000 delegates come from more than 100 countries to discuss the latest developments in thoracic malignancy research. Attendees include surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses and allied health professionals and patients. 
Verwandte Fachgebiete
2.
 
Nutrition and Cancer Care: What Patients want to know
ID
805227
Beginn
07. Dez 2016
Ort
South Kensington, London, Großbritannien
Zusammenfassung
The study day is aimed at dietitians, nurses doctors and other health care professionals working with cancer patients. Training conferences are created for professionals. If you are a patient and require information on Nutrition and Cancer, please consult your Clinical Nurse Specialist for more information or a referral to a Dietitian.

Aim: There is a wealth of information on diet and cancer – not all of it based on good scientific evidence. This study day will aim to look at popular areas of nutrition and cancer and untangle the myths from the evidence. It will focus on topics frequently raised by those with cancer.

Kontakt
Conference Team;     Tel.: [020 7808 2924 / 21];     Email: conferenceteam@rmh.nhs.uk
Themen
Introduction – what people do and why. Did my diet cause my cancer?, What weight should I be during and after treatment? What is the role of exercise?, Do I need to avoid sugar?, I have been told to avoid dairy – is this right?, Should I exclude meat in my diet? Should I eat organic food?, Should I take a vitamin supplement?, Can I take herbal or homeopathic supplements?, Should I take probiotics?, Which superfoods should I have?, Should I follow an acid/ alkaline diet?
3.
 
Cell Symposia: Hallmarks of Cancer
ID
761471
Termin
11. Dez 2016 - 13. Dez 2016
Ort
Gent, Belgien
Zusammenfassung
As one of the most investigated areas in biomedical research, the cancer field is rapidly advancing by translating biological insights towards better detection and therapeutics, including molecular classifications as well as immunotherapies. In the era of the genetically informed, emerging concepts in cancer biology and oncology research are colliding into precision medicine. In order to accelerate the development of personalized cancer therapies and further translate fundamental discoveries into the clinic, there must be open lines of communication at the interface between the lab and the clinic. Our goal in organizing this Cell Symposium, Hallmarks of Cancer, is to convene global leaders in the cancer research arena to enhance our understanding of the key aspects of cancer and how to promote translation of this knowledge into the development of targeted therapeutics. We aim to provide a high-impact, high-profile forum for exchanging ideas and establishing a dialogue amongst clinicians, scientists and drug development companies. Symposium themes: Tumor metabolism, Tumor heterogeneity, Tumor immunology and immunotherapy, Personalized cancer therapy, Metastasis and the tumor microenvironment.
Verwandte Fachgebiete
4.
 
2nd Symposium on “Advances in Cancer Immunology and Immunotherapy”
ID
829810
Termin
15. Dez 2016 - 17. Dez 2016
Ort
Athen , Griechenland
Zusammenfassung
The field of tumor immunology and immunotherapy has entered a new era and our expanding knowledge of immune regulation has already led to innovative therapies for the treatment of cancer. The Symposium aims to bring together clinical and translational oncologists and immunologists to present most recent cutting-edge advances in the stimulating field of cancer immunotherapy. Distinguished invited speakers from leading Institutions in Europe and overseas will report on novel immunotherapeutic strategies leading to effective clinical responses, highlight the significance of prognostic and predictive cancer biomarkers in determining clinical outcome, analyse the principles of cancer immune surveillance and immune suppression, and exploit the potency of combinatorial treatments that can eventually contribute to promising anti-cancer therapeutic interventions. We aim to bring together researchers and clinicians working in these areas, promote interactions between speakers and participants, encourage stimulating discussions, exchange of ideas and experiences, and facilitate the establishment of contacts for new collaborations. In particular, young researchers will be offered the opportunity to present their work to an audience of eminent scientists and receive feedback that will impact on their scientific development in the fields of cancer immunology and immunotherapy.
Themen
Hellenic-immunooncology, immunooncology, Greece, Immunology, Immunotherapy, cancer
5.
 
IOPBS2016 — The 6th International Oncoplastic Breast Surgery Symposium 2016
ID
812574
Termin
16. Dez 2016 - 18. Dez 2016
Ort
Bangkok, Thailand
Zusammenfassung
The congress is being jointly organized by The Thailand Section of the International College of Surgeons (ICS), Society of Plastic and Reconstructive Surgeons of Thailand, Thai Breast disease Society (TBS) and Siriraj Training and Education Center for Clinical Skills [SiTEC]. The past five congresses on International Oncoplastic Breast Surgery Symposium were successful with your support from all corners of the world. The 1st IOPBS in Seoul, Korea, the 2nd IOPBS in Daegu, Korea, the 3rd IOPBS in Tokyo, Japan, the 4th IOPBS in Taipe, Taiwan and the 5th IOPBS in Guangzhou, China.

In addition to the advanced knowledge and insight about the breast cancer diagnosis and treatment, the conference will lay stress on the importance of essential oncologic concept along with integrity of reconstructive surgery. In order to reduce the physical mutilation and improve quality of life, the individualization of oncoplastic surgery principle can be applied to breast cancer patient care. The worldwide list of expert includes the breast cancer experts of oncologic surgery, reconstructive surgery and multidisciplinary team are willing to share their latest findings and valued experience. We believe that it will be an extraordinary academic event with your honorable participation.

Kontakt
Secretariat office;     Tel.: [66817018345];     Email: iopbs.congress@gmail.com
Themen
Oncology, plastic surgery, oncoplastic surgery, breast cancer
Verwandte Fachgebiete
6.
 
ESMO ASIA 2016 Congress
ID
799958
Termin
16. Dez 2016 - 19. Dez 2016
Ort
Singapore, Singapur
Zusammenfassung
This scientific and educational congress is led by an international scientific committee and promotes the sharing of expertise and interaction between regional and international experts in oncology. The programme will offer state of the art science and the current standard of care across all major tumour types.
7.
 
Keystone Symposia: Cell Plasticity within the Tumor Microenvironment
ID
828546
Termin
08. Jan 2017 - 12. Jan 2017
Ort
Big Sky, Montana, Vereinigte Staaten
Zusammenfassung
Scholarship & Discounted Abstract Deadline: Sep 13, 2016; Abstract Deadline: Oct 6, 2016; Discounted Registration Deadline: Nov 8, 2016

During the last decade, it has become unequivocally evident that tumor development is not a cell-autonomous process but rather depends on the intricate reciprocal interplay of mutant tumor cells with their local and distant environments. Composition and polarization of cells in the tumor microenvironment depends on genetic as well as environmental factors and is directly influenced by tumor therapy. Indeed, therapies that aim to shape the local immune milieu and consecutive signaling pathways in both stromal and tumor/stem cells address the complex pathophysiology of tumors more adequately and may therefore add substantial benefits for therapy. An absolute pre-requisite for such an endeavor is a comprehensive understanding of the exact molecular basis of the complex signaling networks in the tumor microenvironment that control the plasticity of both stromal and tumor cells, thereby shaping the complex cellular contexture, which ultimately forms a pro- or anti-tumorigenic milieu. Thus, this symposium aims to gather a comprehensive functional understanding of mediator-dependent cellular and molecular events that are responsible for the plasticity of both stromal and tumor/stem cells. It will bring together experts in cancer, stromal and immune cells to synthesize scientific knowledge about the phenomenon of cell plasticity within the tumor microenvironment, to define molecular and cellular pathways mediating plasticity and to propose approaches to interfere with cell plasticity for a new generation of effective therapeutic approaches in cancer and chronic injury. Importantly, it will bring together interdisciplinary groups of scientists or investigators who normally would not have an opportunity to meet (classical cancer biologists, tumor immunobiologists, stem cell experts and scientists working on stromal cells).

Kontakt
Attendee Services;     Tel.: [970-262-1230];     Email: info@keystonesymposia.org
Themen
Cancer, tumor immunology, basic mechanisms
Verwandte Fachgebiete
8.
 
Keystone Symposia: TGF-ß in Immunity, Inflammation and Cancer
ID
828588
Termin
09. Jan 2017 - 13. Jan 2017
Ort
Taos, New Mexico, Vereinigte Staaten
Zusammenfassung
TGF-beta is a key regulator of immune responses, inflammation and cancer. In addition to the well-established effects of TGF-beta on CD4+ T cell differentiation and reprogramming, TGF-beta also plays critical roles in other immune cells. TGF-beta has also been implicated in the regulation of the interactions among immune cells, microbiota and epithelial cells. In addition to safeguarding immune homeostasis and suppressing chronic inflammation and autoimmunity, TGF-beta is emerging as a potential checkpoint in anti-tumor immunity. Despite great progress in the field, key questions related to TGF-beta functions in immune responses are still largely undetermined. Therefore, it is imperative to understand the cellular and molecular mechanisms by which TGF-beta controls such diverse immune cells. Elucidation of these pathways would allow us to understand the pathogenesis of chronic inflammation, autoimmunity and cancer and aid development of therapeutic practices in experimental and ultimately clinical settings. This meeting will gather together experts in the fields of both TGF-beta signaling and immunology to discuss new findings and update the pivotal role of TGF-beta in immunity, inflammation and cancer, with the aim to lay out the critical and key questions and outline new directions.
Kontakt
Attendee Services;     Tel.: [1+ 970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Themen
cytokines, immunology, inflammation, tumor immunology, t-cell biology, cancer
Verwandte Fachgebiete
9.
 
Immuno World 2017 — Immunotherapy World 2017
ID
845018
Termin
18. Jan 2017 - 20. Jan 2017
Ort
Miami, Vereinigte Staaten
Zusammenfassung
After years of posting impressive clinical results and pushing analyst projections to greater and greater heights, immuno-oncology has solidified its status as the most exciting development in cancer treatment for a long time. Now that checkpoint inhibitors have uncloaked cancer cells, drug developers are investigating dozens of immune drug cocktails (everything from CAR-T to antibodies, vaccines and other cellular therapies) to find well-tolerated treatments which could become the first-in-line to fight cancer in patients.
Kontakt
Carina Hunter;     Tel.: [+44(0)2073847897];     Email: team@phacilitate.co.uk
Themen
immuno, immunotherapy, oncology, R&D, regulatory, supply chain, logistics, lab sessions,
10.
 
Keystone Symposia: PI3K Pathways in Immunology, Growth Disorders and Cancer
ID
829963
Termin
19. Jan 2017 - 23. Jan 2017
Ort
Santa Fe, Vereinigte Staaten
Zusammenfassung
The overall goal for this meeting is to bring together scientific leaders and trainees with a common interest in PI3Ks and relevant downstream physiological processes. It will address advances in basic molecular and cellular mechanisms that are regulated by PI3Ks, other PI kinases and, their cognate phosphatases; highlight new advances in the characterization of PI3K pathway alterations in genetic syndromes that affect growth and the immune and nervous systems; and provide an important update on the clinical development of PI3K pathway inhibitors, and implications for the burgeoning field of cancer immunotherapy. Whole exome sequencing studies have increasingly implicated PI3K signaling in diseases (immune, growth and neurological disorders) which may benefit from drugs currently in development for cancer and inflammation. This meeting will be an important forum for discussing approaches to treating these additional disorders.
Kontakt
Attendee Services;     Tel.: [970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Themen
Immunology, cancer, biochemistry
11.
 
ECCO2017 — European Cancer Congress 2017
ID
806244
Termin
27. Jan 2017 - 30. Jan 2017
Ort
Amsterdam, Niederlande
Zusammenfassung
The European Cancer Congress is the multidisciplinary evidence based meeting for all cancer types, addressing all oncology disciplines and related healthcare professions. ECCO2017 will have a direct impact on daily clinical practice. Focusing on phase III data, this scientific meeting will put the new evidence into perspective for a multidisciplinary audience by critically reviewing it in expert panels. Leading oncologists will address the value of these potentially practice changing treatments by reviewing their clinical benefits and cost. Experts, patient advocates and the audience will determine whether the data really do support changes in clinical practice.
Kontakt
Congress Secretariat;     Tel.: [+32 (0)2 775 02 01];     Email: info@eccocongress.org
Themen
cancer, oncology, precision medicine, multidisciplinary, cancer congress,
12.
 
Keystone Symposia: Epigenetics and Human Disease – Progress from Mechanisms to Therapeutics
ID
832995
Termin
29. Jan 2017 - 02. Feb 2017
Ort
Seattle, Washington, Vereinigte Staaten
Kontakt
Attendee Services;     Tel.: [1+ 970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Themen
Genetics, genomics, basic mechanisms, molecular biology, cancer
13.
 
Complementary Therapies — The Use of Essential Oils in a cancer Care Environment 2 Day Course
ID
806418
Termin
30. Jan 2017 - 31. Jan 2017
Ort
South Kensington, London, Großbritannien
Kontakt
Conference Team;     Tel.: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Themen
Audience: This two day introductory course is suited to aromatherapists who are already working with essential oils in a cancer care environment. Due to the structure of this course it is not possible to book for a single day. Aims:The purpose of this two day course is to promote discussion, link essential oil research to sound and effective practice and to improve aromatic interventions for people with cancer.
Verwandte Fachgebiete
14.
 
Clinical Aromatherapy in End of Life Care — Aromatic Support in the dying process
ID
806397
Beginn
01. Feb 2017
Ort
South Kensington, London, Großbritannien
Kontakt
Conference Team;     Tel.: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Themen
Topics include:The dynamics of the dying process / The signs and symptoms that death is approaching Key issues include working with:Reduced state of consciousness, Disorientation, Restlessness, terminal agitation, Mouth dryness, Circulatory changes, Malodour due to incontinence, wounds, Chest congestion, increased oropharyngeal secretions, Breathing pattern changes, Pain, Key essential oils for the dying phase, Creating a supportive aromatic environment, Aromatic support for the family, Aromatherapy limitations and contraindications,
15.
 
Immuno-Oncology 360°
ID
851261
Termin
01. Feb 2017 - 03. Feb 2017
Ort
New York, Vereinigte Staaten
Zusammenfassung
The 3rd annual Immuno-Oncology 360° is the only conference that provides a unique 360-degree approach addressing the most-up-to-date information regarding business aspects, clinical advancements and scientific data that will help accelerate clinical trials and FDA approval, ultimately transforming the way cancer is treated. Designed by lead advisors and co-chair's Dr. Axel Hoos (GSK) and Dr. James Gulley (NCI) along with the support of the Cancer Research Institute (CRI), The Society for Immunotherapy of Cancer (SITC) and The Association of Cancer Immunotherapy (CIMT).
Kontakt
Onalee Smith;     Tel.: [646-350-2580 x308];     Email: service@tcfllc.org
16.
 
Pain Management — The Use of Essential Oils for Pain Management
ID
806351
Beginn
02. Feb 2017
Ort
South Kensington, London, Großbritannien
Kontakt
Conference Team;     Tel.: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Themen
Aims and Objectives: Taking a whole person approach and linking this to a strong evidence base, delegates will increase their knowledge, skills and confidence in using essential oils safely and effectively with individuals in pain. Specific essential oils with good evidence for their pain relieving effects will also be profiled in this study day.
17.
 
EMBL-Cancer Core Europe Conference: Cancer Immunotherapy
ID
818148
Termin
02. Feb 2017 - 04. Feb 2017
Ort
Heidelberg, Deutschland
Zusammenfassung
The 2017 EMBL-Cancer Core Europe Conference on Cancer Immunotherapy will cover highly relevant sub-disciplines of cancer immunology with a special focus on personalised immunotherapy.

The European Molecular Biology Laboratory (EMBL) and Cancer Core Europe - a consortium of Europe's 6 leading Comprehensive Cancer Centers (Gustave Roussy Cancer Campus Grand Paris, France; Cambridge Cancer Centre, United Kingdom; Karolinska Institutet, Sweden; Netherlands Cancer Institute (NKI), Vall d’Hebron Institute of Oncology, Spain and the German Cancer Research Centre (DKFZ) with it's National Center for Tumour Diseases (NCT) Heidelberg) - are proud to join forces to host the first EMBL-Cancer Core Europe Conference on Cancer Immunotherapy.

Kontakt
EMBL Marketing;     Tel.: [4962213878797];     Email: marketing@embl.de
Themen
cancer, immunotherapy, tumour microenvironment
18.
 
Respiratory Conditions — Essential Oils for Respiratory Conditions
ID
806449
Beginn
03. Feb 2017
Ort
South Kensington, London, Großbritannien
Themen
Taking an evidence-based approach we shall explore: an overview of the respiratory system, specific essential oil and component actions that are relevant including: secretolytic, secretomotor, bronchospasmolytic, mucolytic, calming, antitussive and antimicrobial, key aromatherapy applications for respiratory care (inhalers, inhalation devices, diffusion, chest rubs, massage, aroma patches, allied techniques), a spotlight on eight essential oils that have particular value in this area, holistic and clinical approaches to breathlessness, aromatherapy as a part of a multidisciplinary approach to managing breathlessness, safety issues including risk of bronchospasm, debate about essential oils and oxygen therapy and appropriate dosing.
Verwandte Fachgebiete
19.
 
Keystone Symposia: Noncoding RNAs – From Disease to Targeted Therapeutics
ID
833383
Termin
05. Feb 2017 - 09. Feb 2017
Ort
Banff, Alberta, Kanada
Zusammenfassung
It has become apparent over the last decade that small and long noncoding RNAs play a major role in the regulation of gene expression and disease. While much emphasis has been centered on the role of noncoding RNAs in human disease, a gap remains in utilizing this knowledge to develop target specific approaches to disrupting noncoding RNA pathways for therapeutic gain. This meeting will for the first time bring together an interdisciplinary group of basic and applied noncoding RNA scientists in an effort to translate our current understanding of noncoding RNA biology into meaningful therapeutics for many of those diseases afflicting society. To accomplish this goal, the meeting will aim to: (1) Introduce the broad genome-wide basic fabric of noncoding RNA regulation and form and function in the cell; (2) Focus on direct RNA/chromatin/DNA or RNA/protein interactions with candidate disease-relevant model systems; and (3) Highlight synthetic biological approaches to developing RNA or oligonucleotide mimics to target and/or disrupt particular disease-relevant noncoding RNA pathways. The goal of this meeting is to bring together basic and applied scientists working on noncoding RNAs in an effort to not only better understand the role noncoding RNAs play in the regulation of disease-relevant genes but also the emerging ability to utilize this knowledge to develop targeted therapeutics, an eventuality that heralds a new frontier in drug development and therapeutics.
Kontakt
Attendee Services;     Tel.: [1+ 970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Themen
genetics, genomics, RNA, molecular biology, transcription
20.
 
SPECT/CT — 6th annual SPECT/CT symposium: Current status and future directions
ID
852456
Termin
09. Feb 2017 - 10. Feb 2017
Ort
London, Großbritannien
Zusammenfassung
Following the success of the five previous SPECT/CT symposiums, this event returns for a 6th year with a brand-new upgraded two-day format.
Kontakt
Malini Banerjee;     Tel.: [2036682226];     Email: Malini.Banerjee@bir.org.uk
Themen
SPECT/CT, CT, SPECT, clinical, applications, physics, technical, imaging, bone, orthopaedic, oncology, oncological, scan, malgnant, disease, cardiac, amyloid, hip, pain, pelvis, ankle, feet, wrist, hand, prosthesis, spine, infection, musculoskeletal, MSK, quality assurance, quality care, patient positioning, image acquisition, artefacts, DRLs, coding
21.
 
PRIMO — 2017 Practical Considerations in Immuno and Molecular Oncology (PRIMO) Annual Meeting
ID
807186
Termin
09. Feb 2017 - 12. Feb 2017
Ort
Maui, Vereinigte Staaten
Zusammenfassung
The Practical Considerations in Immuno and Molecular Oncology (PRIMO) Meeting is an annual CME-certified conference to help practicing providers keep up with the latest advances in immuno and molecular targeted therapies. This year’s meeting is scheduled to take place February 9-12, 2017 in Wailea Beach, Maui, Hawaii and will help providers address real world issues on how and when to optimally integrate these new therapies into their clinical practice, and also provide insight into new advances in immune and molecular targeted therapies that are expected to report new data in 2017.The PRIMO Meeting is for those who want a streamlined review of the most recent advances in immuno and molecular oncology delivered by some of the top experts in their respective field. This meeting is for practicing oncologists, hematologists, research fellows, and nurses. Interested parties can log on to www.primomeeting.org for more information.
Kontakt
Jen Mahon;     Tel.: [1-855-677-4668];     Email: info@primomeeting.org
Themen
oncology, continuing medical education, immunotherapy
22.
 
Neuro Oncology — Paediatric Neuro-Oncology Study Day
ID
806447
Beginn
13. Feb 2017
Ort
South Kensington, London, Großbritannien
Zusammenfassung
Aim: The day will update practitioners on current practice in managing this patient group and where possible the evidence base to inform practice. It will raise awareness of issues specifically related to children’s palliative care.
Kontakt
Conference Team;     Tel.: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Themen
Topics to include: Overview of childhood brain tumours, Treatment options available currently / new treatments on horizon, Neurosurgical options, Use of Radiotherapy, Nursing case study, Supporting children with play therapy, Psychological considerations, Neuro rehabilitation Patient experience,
Verwandte Fachgebiete
23.
 
APBCS — 6th Asia-Pacific Breast Cancer Summit
ID
832772
Termin
17. Feb 2017 - 19. Feb 2017
Ort
Hong Kong, China
Zusammenfassung
Being one of the most common cancers in women, both in developed and underdeveloped regions of the world, there is a need to discuss the latest aspects of breast cancer and its alarming increase. During the past four years, the Asia Pacific Breast Cancer Summit has been successfully addressing vital topics regarding this prevalent disease.

In 2017, the 6th Asia Pacific Breast Cancer Summit will once again to bring together international & regional faculty experts in breast cancer to cover surgical, radiation and medical oncology related topics on early and advanced breast cancer management.

Kontakt
Tripti Vachher;     Tel.: [+97143116300];     Email: breastsummit@mci-group.com
Themen
Cancer, Breast cancer
Verwandte Fachgebiete
24.
 
Training — Cancer Survivorship Summit: Improving outcomes for people living with and beyond cancer
ID
853946
Beginn
20. Feb 2017
Ort
London, Großbritannien
Zusammenfassung
This national annual summit takes a practical approach to improving practice and outcomes for those living with and beyond cancer, moving from surviving to thriving. Through national updates and practical case studies the conference aims to support you to deliver NHS England’s for Cancer Survivorship and develop effective cancer survivorship support and services. There will be an extended focus on meeting the unmet needs of people living with and beyond cancer, accelerating the roll-out of stratified follow up pathways and the commissioning of holistic packages of support, and ensuring every person with cancer will have access to relevant elements of the Recovery Package. The conference will also update delegates on the development of the national metric for long term quality of life for cancer patients. Follow the conference on Twitter #cancersurvivorship A 20% discount is available by quoting ref: hcuk20c-s when booking.
Kontakt
Tel.: 0044/1932 429933;     Email: kerry@hc-uk.org.uk
Themen
Cancer, Oncology
25.
 
2nd Annual Immuno-Oncology Summit Europe
ID
829815
Termin
20. Feb 2017 - 24. Feb 2017
Ort
London, Großbritannien
Zusammenfassung
Following the success of the 2016 conference in London, we present the Immuno-Oncology Summit Europe 2017. Once again our venue is in central London, an ideal meeting place for international academic and industry experts. Attendees can now experience an entire week of updates and discussion. In Novel Approaches for Cancer we will focus on T cells and their receptors including chimeric antigen receptor (CAR-T) technology, bispecifics, preclinical models, and targets and lead selection. Immunomodulatory Approaches will look at advances in checkpoint inhibitors, agonistic receptor engagement, NK, macrophage and dendritic cell activation, Fc-engineering technologies, cytokine-based therapies and oncolytic vaccines. Combination Immunotherapy will examine design of immunotherapy combinations, combination strategies and provide preclinical and clinical updates.
Kontakt
Jaime Hodges;     Tel.: [781-972-5400];     Email: chi@healthtech.com
26.
 
FACTOR — FACTOR Miami Osteosarcoma Conference 2017
ID
842114
Termin
24. Feb 2017 - 25. Feb 2017
Ort
Coral Gables, Miami area, FL, Vereinigte Staaten
Zusammenfassung
This is a unique inaugural conference dedicated to osteosarcoma in which researchers, clinicians and the patient community will interact. FACTOR stands for: Funding, Awareness, Collaboration, Trials, Osteosarcoma Research, which is the aim of the conference.It is planned to have inter-disciplinary discussions [involving pathologists, surgeons, geneticists, oncologists, radiologists] in three broad sessions : a session steered by clinicians on challenges in contemporary treatments, a session steered by researchers on innovative models and treatment approaches that are in progress or planned, with a final session steered by a mix of both, on the road ahead, and novel solutions to meet challenges and improve outcomes.The conference aims are to significantly improve osteosarcoma awareness and patient outcomes through collaborative disease management approaches, clinical trials and dedicated osteosarcoma research; to collectively brainstorm on the challenges and come up with collaborative solutions on a fast track; to create a symbiotic bridge between the osteosarcoma medical community and the patient community for an improved understanding of patient challenges and solutions; to provide a platform to various osteosarcoma advocacy/support groups to better collaborate and optimize their resources; to evaluate funding needs for research and provide impetus to fundraising strategies [by various advocacy groups] and be a dedicated forum to review progress on an annual basis on various osteosarcoma disease management initiatives.
Kontakt
Mohan Anand;     Tel.: [+1 778-980-2627];     Email: info@mibagents.org
Themen
osteosarcoma, pediatric cancers, bone cancer, metastasis, cancer patient advocacy, cancer media awareness, research, patient support, research, funding, prognosis,
27.
 
IGSHNO — Indo Global summit of Head & Neck Oncology
ID
824400
Termin
24. Feb 2017 - 26. Feb 2017
Ort
Jaipur, Rajasthan, INDIA, Indien
Kontakt
Dr Anil K Gupta;     Tel.: [+91-9829052417];     Email: igshno2017@gmail.com
Themen
Indo- Global Summit on Head & Neck Oncology (IGSHNO), BMCON-IV, Multidisciplinary Approach – Expanding Treatment Horizons, Head & Neck Cancer, Oncosurgery, Onco-plastic surgery, Medical Oncology, Radiation Oncology, ENT, Dental (Maxillofacial, Prosthodontics etc.), Palliative care and Rehabilitation, Cancer Prevention, Cancer psychology, chnological advances and innovation
28.
 
Cancer Conference
ID
781859
Termin
24. Feb 2017 - 27. Feb 2017
Ort
Carlsbad, Vereinigte Staaten
29.
 
Frontiers in Cancer Immunotherapy
ID
824381
Termin
27. Feb 2017 - 28. Feb 2017
Ort
New York, NY, Vereinigte Staaten
Zusammenfassung
This 2-day scientific symposium will explore emerging findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches in cancer treatment. The event will convene basic, preclinical, and clinical researchers active in the field of cancer immunotherapy, alongside industry representatives and government stakeholders. Dr. James Allison, Executive Director of the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center and a pioneer in the field of cancer immunotherapy, will commence the conference with a Keynote Address. Plenary speakers will present on an array of topics, including: the evaluation of combination therapy strategies to improve clinical benefit; the development of immune-monitoring strategies for the identification of relevant prognostic and predictive biomarkers; the development of strategies to overcome immune tolerance; and the incorporation of genomics into immunotherapeutic research and clinical trials.
Themen
Immunotherapy, Oncology, Immunology, Therapeutics, Clinical Trials, Vaccines, Diagnostics, Biomarkers, Genomics, Epigenomics, Epigenetics, Drug Discovery, Cancer
30.
 
2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference
ID
813965
Termin
27. Feb 2017 - 02. Mär 2017
Ort
Cancun, Mexiko
Zusammenfassung
Defect in DNA damage repair and checkpoint control is the underlying mechanism for tumorigenesis, since it allows the accumulation of multiple genetic alternations, which are essential for the initiation of tumorigenesis. This has been clearly illustrated to be the cause of several human cancer-prone syndromes and also revealed by recent human genome studies. On the other hand, defective DNA repair and checkpoint activation also make cancer cells more vulnerable for particular DNA damaging agents or inhibitors that specifically disrupt some of these checkpoint pathways. With the increasing understanding of defects in DNA repair and checkpoint control in tumorigenesis, there are extensive interests in exploring these deficiencies, especially taking advantage of the synthetic lethality concept and targeting particular DNA repair and checkpoint pathways for cancer therapy. The purpose of this conference is to bring together basic, translational and clinical investigators and discuss the current and future directions, opportunities and obstacles in the development of these anti-cancer modalities and how to best apply these concepts in clinical practice.
Kontakt
Jack Peters;     Email: jack@fusion-conferences.com
Themen
Cancer, Cancer Therapy, DNA
31.
 
AEK — 19th International AEK Cancer Congress
ID
811359
Termin
01. Mär 2017 - 03. Mär 2017
Ort
Heidelberg, Deutschland
Verwandte Fachgebiete
32.
 
Keystone Symposia - Adaptations to Hypoxia in Physiology and Disease
ID
825140
Termin
05. Mär 2017 - 09. Mär 2017
Ort
Whistler, British Columbia, Kanada
Zusammenfassung
Cellular responses to changes in oxygen availability have important implications for both physiology and pathophysiology, in particular in the setting of solid tumor progression. A number of hypoxia-inducible pathways have been characterized, such as the large transcriptome regulated by hypoxia-inducible factors (HIFs). However, many other oxygen-sensing pathways exist within the cell. The aim of this meeting is to disseminate up-to-date information on basic mechanisms of cellular and tissue hypoxia responses, and discuss the impact of these responses on physiology and cancer, with an emphasis on HIF-independent, but nevertheless fundamental, oxygen-sensing pathways. Outcomes of this meeting will include the dissemination of new scientific knowledge, the discussion of new methodologies, the education of graduate students and postdoctoral fellows in this discipline, and promotion of new collaborations between clinicians, basic researchers and industrial partners. This will be the eighth Keystone Symposia meeting on Hypoxia, which brings together academic, clinical and industrial researchers to enhance synergy between these groups and develop translational strategies for targeting hypoxic stress responses for therapeutic benefit.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
hypoxia, tumor metabolism, hypoxic influences, intracellular homeostasis, tumor microenvironment, tumor stroma, tumor progression, o2 availability, stress responses
Verwandte Fachgebiete
33.
 
Keystone Symposia - Tumor Metabolism: Mechanisms and Targets
ID
825190
Termin
05. Mär 2017 - 09. Mär 2017
Ort
Whistler, British Columbia, Kanada
Zusammenfassung
This conference is on the rapidly moving field of tumor metabolism and its implications in cancer development, progression and therapy. Experts from distinct fields of research will be brought together to present their latest discoveries on tumor metabolism, which is an inherently interdisciplinary field. Defining the diversity of metabolic strategies employed by cancer cells and how the genetic events underlying different types of cancer, as well as the tumor microenvironment, influence these metabolic properties is a major goal of this meeting. In addition, a combination of basic, translational and clinical studies will be presented, with the goal of identifying promising avenues in tumor metabolism that impact our understanding, diagnosis and treatment of cancer. In addition to a stellar line up of invited speakers, short talks and poster presentations will provide opportunities for researchers at all levels to discuss their most current work in this field. This meeting provides an excellent opportunity to share knowledge and methodology in tumor metabolism research in a collegial and social atmosphere.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
tumor metabolism, hypoxia, oncogenic control, metabolic strategies, metabolic adaptions, metabolic vulnerabilities, tumor progression, tumor supression
34.
 
APCCC 2017 — Advanced Prostate Cancer Consensus Conference (APCCC) 2017
ID
801229
Termin
09. Mär 2017 - 11. Mär 2017
Ort
St. Gallen, Schweiz
Zusammenfassung
In advanced prostate cancer, rapid and successful drug development has resulted in multiple treatment options, requiring careful decision making for individual patients. Clinicians face the increasingly difficult task of choosing from multiple potentially effective treatments that are also costly and potentially toxic. The inaugural Advanced Prostate Cancer Consensus Conference (APCCC) did provide a forum for discussion and debates on current treatment options for men with advanced prostate cancer. The conference concluded with voting by the panel on pre-defined consensus questions, targeting areas of primary clinical relevance. Following the conference a manuscript with containing the expert recommendations was published at Annals of Oncology.
Verwandte Fachgebiete
35.
 
2nd EACR-OECI Conference: Making it Personal: Cancer Precision Medicine
ID
842142
Termin
13. Mär 2017 - 16. Mär 2017
Ort
Amsterdam, Niederlande
Zusammenfassung
This conference will update you on advances in personalised cancer medicine, focusing on targeted and immunological therapeutic approaches. It will cover the challenges of tumour heterogeneity, drug resistance and the influence of the tumour microenvironment. The conference will bring together basic, translational and clinical scientists, as well as physicians engaged in the challenges of personalised medicine, the development of new therapeutics and clinical implementation.
Kontakt
Kathryn Wass;     Email: kathryn.wass@nottingham.ac.uk
Themen
tumour evolution, tumours, tumors, organoids, PDX, CTX, ODX, metabolome targets, microenvironment, immune approaches, implementing genomics, clinical practice, tumour heterogeneity, drug resistance
36.
 
ICTO2017 — International Congress on Clinical Trials in Oncology and Hemato-Oncology
ID
819900
Termin
16. Mär 2017 - 17. Mär 2017
Ort
London, Großbritannien
Kontakt
Debi Bert;     Email: debi@bioevents.net
Themen
Oncology, Hemato-Oncology, Clinical Trials
Verwandte Fachgebiete
37.
 
3rd Annual Spring Cactus Cancer Conference
ID
852718
Termin
16. Mär 2017 - 18. Mär 2017
Ort
Scottsdale, AZ, Vereinigte Staaten
Zusammenfassung
3rd Annual Spring Cactus Cancer Conference will feature updates on Melanoma, Integrative Oncology and Lung Cancer. Speakers confirmed include: Donald Abrams, MD (UCSF Osher Center for Integrative Medicine), Christopher Barker, MD (Memorial Sloan Kettering Cancer Center) and Brian Lawenda, MD (21st Century Oncology, Northwest Cancer Clinic) . This Conference has been approved for 12.0 AMA PRA Category 1 Credits. 12.0 AAPA Category 1 credits and 12.0 hours Category A credits with the American Society of Radiologic Technologists.
Kontakt
Nancy Robinson;     Tel.: [828-277-9706];     Email: sha@shallc.net
38.
 
2nd Personalized Medicine Conference
ID
853098
Termin
17. Mär 2017 - 20. Mär 2017
Ort
Cancun, Großbritannien
Zusammenfassung
Join us for the 2nd Personalized Medicine conference taking place from 17-20 March 2017 in Cancun, Mexico to discuss to discuss precision diagnostics, cancer genomics, biomarkers, computational imaging, bioinformatics and data analytics/big data. The personalized medicine space has been defined by recent regulatory approvals of targeted therapeutics in oncology and co-developed diagnostics used in patient selection. However, a broader view of personalized medicine encompasses other disease areas, newer therapeutic regimens, new therapeutic platforms and broad computational approaches. This conference will weave together many of these new approaches and their relevance to personalized medicine.
Kontakt
Laura Trundle;     Tel.: [+44 (0) 1638724137];     Email: laura@fusion-conferences.com
Themen
precision diagnostics, cancer genomics, biomarkers, computational imaging, bioinformatics and data analytics/big data.
39.
 
Keystone Symposia - Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology
ID
825329
Termin
19. Mär 2017 - 23. Mär 2017
Ort
Whistler, British Columbia, Kanada
Zusammenfassung
The fields of cancer immunology and immunotherapy continue to make great strides in providing both a comprehensive understanding of the basic mechanisms underlying tumor-immune system interactions and applying this knowledge to the development of effective immune-based cancer therapies. This Keystone Symposia meeting is organized to highlight recent insights into the complex roles of immune components and pathways in controlling or alternatively promoting cancer and to showcase recent uses of cancer vaccines, checkpoint blocking strategies, adoptive cell therapies and cellular engineering approaches, either as mono- or combinatorial therapies, that have resulted in durable, effective and safe therapeutic responses to an increasing number of cancer patients. Part of the meeting will also focus on new, developing technologies that are likely to expand our capacity to monitor the effects of cancer immunotherapy with a precision, refinement and at a level that has not been possible in the past.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
cancer immunology, cancer immunotherapy, immunosuppressive cells, tumor microenvironment, immune checkpoints, combinatorial approaches, cancer vaccines, inflammation, cellular engineering, nex-gen technologies
40.
 
ITOC4 — 4th ImmunoTherapy of Cancer Conference
ID
848875
Termin
20. Mär 2017 - 22. Mär 2017
Ort
Prag, Tschechische Republik
Zusammenfassung
The ITOC series of conferences is the premier meeting for education, scientific exchange and networking within cancer immunotherapy. The fourth edition (ITOC4) will take place on Prague, Czech Republic, from 20 to 22 March 2017. It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research. The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development.
Kontakt
Catherine Tomek (Congress Office);     Tel.: [+431405138318];     Email: itoc@medacad.org
Themen
Preclinical models, Co-stimulatory agonists and co-inhibitory antagonists, Immunogenomics, Therapeutic modulation of immune checkpoints, Combination therapy, Anti-cancer vaccines, Engineered T-cell therapy, Monitoring of immunotherapy
41.
 
Palliative radiotherapy
ID
852411
Beginn
24. Mär 2017
Ort
London, Großbritannien
Zusammenfassung
Palliative radiotherapy is used to relieve our patients of pain or other distressing symptoms of their cancer and to improve their quality of life. It has traditionally been associated with the use of simple planning and delivery techniques but there is now increasing interest in the use of the latest treatment techniques such as Intensity-Modulated Radiation Therapy (IMRT) and Stereotactic ablative radiotherapy (SABR) to provide more effective and durable control and reduce toxicity. Alongside these developments, there has also been a change to a more multidisciplinary approach in the management of palliative cancer care with consultant therapeutic radiographers and nurses taking an increasingly active role in the planning of palliative radiotherapy.
Kontakt
Malini Banerjee;     Tel.: [02036682226];     Email: Malini.Banerjee@bir.org.uk
Themen
palliative, radiotherapy, oncology, cancer, quality of life, treatment, technique, IMRT, intensity-modulated radiation therapy, SABR, stereotactic ablative radiotherapy, multidisciplinary, management, therapeutic, radiographer, lung, bone, nodes, brain, VMAT, volumated modulated arc therapy, brachytherapy, isotope therapist, SIRT, selective internal radiation therapy, supportive care, acute, pathway
42.
 
Keystone Symposia - Immune Regulation in Autoimmunity and Cancer
ID
825325
Termin
26. Mär 2017 - 30. Mär 2017
Ort
Whistler, British Columbia, Kanada
Zusammenfassung
While the importance of adoptive and innate immunity has been clear in the pathogenesis of human autoimmune disease resulting in a multitude of immune-based therapeutic approaches, the realization is now apparent that understanding immune evasion by cancer is central in developing curative treatments. This meeting will explore and contrast the underlying immune mechanisms resulting in autoimmunity and tumor evasion. The meeting is innovative in bringing together basic immunologists investigating mechanisms of tolerance with scientists exploring immune mechanisms of autoimmunity and cancer in both patients and experimental models. Thus, this Keystone Symposia meeting will cover the pathways in immunity and tolerance that lead to loss of immunological control, dysregulated immune responses and chronic inflammatory disease or tumor evasion. Presentations will include consideration of preclinical and clinical aspects of a diverse number of autoimmune and inflammatory diseases and cancer. Conference participants engaged in preclinical, translational and clinical research will hopefully engage in continuing conversations and collaborations which, over the long-term, will provide greater insights into the human immune response and allow us to reassess and further explore pathways that are driving autoimmune disease yet in opposition, lead to tumor evasion. Understanding checkpoints in autoimmunity and immune cell tolerance is important for delivering therapies to patients with autoimmune disease and cancer, and this meeting will provide a platform for the cross-pollination of clinical experience and experimental research. Attendees will have learned about the impact of targeted immune-based therapeutics on clinical outcome and, consequently, be able to widen their research scope accordingly.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
Immune Regulation, Autoimmunity, Cancer, Tissue Micro-Immune Environments, Autoimmune Tissue Inflammation, T Cell Tolerance, Effector T Cell Dysfunction, Innate Regulation, B Cell Regulation, Th17 Cell
Verwandte Fachgebiete
43.
 
Oncology Research 2017 — International Conference on Oncology Research
ID
841359
Termin
27. Mär 2017 - 29. Mär 2017
Ort
San Antonio, Vereinigte Staaten
Zusammenfassung
Gavin Conferences invites participants from all over the world to attend “International Conference on Oncology Research” during March 27-29, 2017 at San Antonio, Texas, USA. This international conference provides a platform for researchers and decision makers in cancer research to present their latest findings and learn about all the important developments in cancer research.
Kontakt
Jenny Parker;     Tel.: [6303970234];     Email: oncologyresearch@gavinconferences.net
Themen
Clinical Oncologists, Registered Nurses, Nurse practitioners, Cancer Researchers, Radiologists
44.
 
Keystone Symposia - Genomic Instability and DNA Repair
ID
825315
Termin
02. Apr 2017 - 02. Jun 2017
Ort
Santa Fe, New Mexico, Vereinigte Staaten
Zusammenfassung
Genome stability is the foundation upon which all cellular and organismal processes depend. This conference will grapple with the intricate array of biochemical reactions orchestrated by the cell to replicate, repair and segregate chromosomes accurately despite constant threats from spontaneous and environmentally-induced damage. Defects in these reactions lead to genomic instability, a confirmed driver of cancer and degenerative diseases. Fascinating and therapeutically crucial questions remain about the mechanisms underlying chromosome stability, and cross-disciplinary approaches are required to address them. How do epigenetic chromatin marks influence repair of underlying DNA sequences, and how can we predict the effects of chemotherapeutic agents that alter such marks? To what extent is the nucleus organized into subdomains with distinct functions; how are these subdomains altered when cells move or differentiate? How are the myriad helicases, nucleases and polymerases coordinated to safeguard genome stability, why are these molecules often mutated in human disease, and how can we ameliorate the effects of such mutations? What is the array of strategies available to cancer cells as they achieve unlimited proliferation? This conference has a history of bringing together investigators from diverse subfields who otherwise rarely meet. Cutting-edge concepts in translational, genomic, cellular, molecular, RNA and structural biology will be dissected to take the conversation to unprecedented levels of depth and breadth. The concurrent conference on “DNA Replication and Recombination” will provide additional opportunities for cross-talk. Both conferences are committed to nurturing interactions among longtime experts in the field with students, postdocs and investigators new to the field.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
Genomic Instability, DNA Repair, RNA Metabolism, Chromatin Structure, DNA Replication/Repair, Nuclear Dynamics, Cell Cycle Regulation, DNA Damage Response, Replication Coupled Repair, Telomeres, Centromeres
Verwandte Fachgebiete
45.
 
CancerMetastasis — Cancer Metastasis through the Lymphovascular System: Biology & Treatement, 7th International Symposium
ID
813125
Termin
20. Apr 2017 - 22. Apr 2017
Ort
San Francisco, Vereinigte Staaten
Zusammenfassung
This is a very exciting time to be involved in cancer research! The 7th iteration of the Symposium brings together international experts in oncology, immunobiology, pharmacology, molecular biology and molecular imaging to discuss preclinical, translational and clinical advances in diagnosing, treating and preventing cancer metastasis as we enter the era of precision medicine. With advancements in cancer care and patient-centered treatment planning, cancer survivors today live longer and enjoy a vastly improved quality of life than thought imaginable. We hope you will participate in Cancer Metastasis through the Lymphovascular System: Biology & Treatment, 7th International Symposium, scheduled for April 20-22, 2017 in San Francisco, California.
Kontakt
Joan Oefner;     Tel.: [491711049181];     Email: joefner@cancermetastasis.org
Themen
immunotherapy, oncology, breast cancer, melanoma, lymphedema, radiation therapy, metastasis, cancer biology, cancer treatment, cancer microenvironment, tumor, Lymphatic System, molecular biomarkers, Sentinel Lymph Nodes
Verwandte Fachgebiete
46.
 
7th EACR-OECI Joint Training Course: Molecular Pathology Approach to Cancer
ID
842254
Termin
08. Mai 2017 - 10. Mai 2017
Ort
Amsterdam, Niederlande
Zusammenfassung
This course aims to provide a comprehensive overview of the state-of-the-art molecular pathology approaches and their application, and a discussion of current genomics and molecular pathology of solid malignancies. The course will provide knowledge beneficial for practising pathologists and oncologists, residents and fellows in pathology and oncology, and molecular biologists with interest in diagnostic and molecular pathology.
Kontakt
Kathryn Wass;     Email: kathryn.wass@nottingham.ac.uk
Themen
molecular pathology, precision medicine, genomic analyses, genetic determinants, tumourigenesis, cancer progression, genomics, solid malignancies, oncology, immunotherapy, parallel sequencing, breast cancer, transcriptomic, genetic biomarkers, endometrial cancers, melanoma, gastrointestinal stromal tumours, lung; colorectal, sarcomas, prostate, kidney, central nervous system
47.
 
iwCLL — XVII International Workshop on Chronic Lymphocytic Leukemia
ID
823304
Termin
12. Mai 2017 - 15. Mai 2017
Ort
New York City, Vereinigte Staaten
Zusammenfassung
The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is a biannual meeting focused solely on advancing the understanding and treatment of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders. Founded in 1979, iwCLL is now the largest international meeting dedicated to these blood cancers, leading the scientific discussion on both laboratory-based research and clinical practice. The biannual meeting provides a forum that facilitates the exchange of information and encourages collaboration among international leaders and scientists interested in CLL and other lymphoproliferative disorders.
Kontakt
Kraig Steubing;     Tel.: [1-888-476-9129];     Email: iwcll2017@bioascend.com
Themen
CLL, Lymphoproliferative Disorders
Verwandte Fachgebiete
48.
 
2nd Annual Advances in Immuno-Oncology Congress
ID
842308
Termin
15. Mai 2017 - 16. Mai 2017
Ort
London, Großbritannien
Zusammenfassung
Oxford Global are proud to present the 2nd Annual Advances in Immuno-Oncology Congress, taking place 15-16 May 2017 in London UK. The event features 200 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies. 36 presentations and case studies will focus on the key developments in Immuno-Oncology with specific reference to the discovery of therapeutic areas, pre-clinical and clinical studies, screening, assays and modelling.The congress has 4 interactive streams: Discovery of Immuno-Oncology Therapies; Pre-clinical Immuno-Oncology; Screening, Assays and Modelling in Immuno-Oncology and Immuno-Oncology: Therapeutic Approaches, Clinical Research and Clinical Trials
Kontakt
Danielle Dalby;     Tel.: [01865248455];     Email: d.dalby@oxfordglobal.co.uk
Themen
immuno-oncology, oncology, immunology, screening, assays, modelling
Verwandte Fachgebiete
49.
 
American Society of Clinical Oncology 2017 Annual Meeting
ID
651355
Termin
02. Jun 2017 - 06. Jun 2017
Ort
Chicago, Vereinigte Staaten
Zusammenfassung
Attendees of the 2017 Annual Meeting will find cutting-edge scientific presentations and comprehensive educational content. The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting — "Science and Society." Prospective attendees can familiarize themselves with some basic information, including: The various session types that will take place at the Annual Meeting, The Cancer Education and Scientific Program Committees.
50.
 
Pancreatic Cancer 2017 — 2nd International Conference on Pancreatic Cancer & Liver Diseases
ID
853348
Termin
12. Jun 2017 - 13. Jun 2017
Ort
London, Großbritannien
Zusammenfassung
Pulsus invites you to attend 2nd International Conference on Pancreatic Cancer & Liver Diseases (Pancreatic Cancer 2017) to be held in London, UK during June 12-13, 2017.We will be discussing in detail the anatomy, physiology, pathology and treatment of pancreatic diseases ranging from pancreatitis to pancreatic cancer in this conference. Speakers attending our conference are experts in the field and have been involved in research of novel techniques in the treatment of pancreatic ailments.
Kontakt
Sandra Johnson;     Tel.: [+44-203-769-1765];     Email: sandraclinicalgastro@gmail.com
Themen
Pancreatic Cancer, Oncology, Pancreas, Gastroenterology, Hepatology, Medicine, Hepatitis, Vaccines, Liver Diseases, Fatty-acid liver diseases, Pharmaceutical drugs for pancreatic cancer, Pharmaceutical drugs for liver diseases, IPMN Pancreas
Verwandte Fachgebiete
51.
 
DEGRO 2017 — 23. Jahrestagung der Deutschen Gesellschaft für Radioonkologie
ID
841343
Termin
15. Jun 2017 - 18. Jun 2017
Ort
Berlin, Deutschland
Kontakt
Annika Bleckert;     Tel.: [030 204590];     Email: degro@mci-group.com
Themen
Radiooncology
Verwandte Fachgebiete
52.
 
19th MCCR Workshop — ECCO-AACR-EORTC-ESMO Workshop on Methods in Clinical Cancer Research
ID
842230
Termin
17. Jun 2017 - 23. Jun 2017
Ort
Zeist, Niederlande
Zusammenfassung
The ECCO-AACR-EORTC-ESMO Workshop on Methods in Clinical Cancer Research is an educational programme that introduces junior clinical oncologists in any oncology subspecialty to the principles of good clinical trial design.
Kontakt
Email: workshop@ecco-org.eu
Themen
Clinical trial design, Junior clinical oncologists, Oncology, Workshop
53.
 
DGPatho — 101. Jahrestagung der Deutschen Gesellschaft für Pathologie
ID
842262
Termin
22. Jun 2017 - 24. Jun 2017
Ort
Erlangen, Deutschland
Kontakt
Tel.: [030 204590];     Email: dgpatho@mci-group.com
Themen
Pathology, Genetics
Verwandte Fachgebiete
54.
 
GI-Oncology 2017 - 13. Interdisziplinäres Update
ID
841370
Beginn
24. Jun 2017
Ort
Wiesbaden, Deutschland
Kontakt
Andreas Kandler;     Tel.: [+49 (0)89 549096-77];     Email: gi-oncology@mci-group.com
Verwandte Fachgebiete
55.
 
EACR-AACR-SIC 2017 Special Conference
ID
842327
Termin
24. Jun 2017 - 27. Jun 2017
Ort
Florenz, Italien
Zusammenfassung
Hosted by the European Association for Cancer Research (EACR), the American Association for Cancer Research (AACR) and the Italian Cancer Society (SIC), the EACR-AACR-SIC Special Conference 2017 “The Challenges of Optimising Immuno and Targeted Therapies: From Cancer Biology to the Clinic” will build on the success of the previous conference, which was widely praised for the quality of its programme and inspirational contributions. The conference format is designed to bring together basic, translational and clinical researchers, as well as researchers working on the development of new targeted therapeutics. Leading experts will present the latest achievements of multidisciplinary research dealing with drug action and resistance and highlight challenges that require a concerted multidisciplinary effort.
Kontakt
Email: EAS2017@ecco-org.eu
Themen
Oncology, Immunotherapy, Targeted therapies, Translational research, Clinical researcher, Targeted therapeutics, Drug resistance
56.
 
2nd DNA Replication as a Source of DNA Damage Conference
ID
814126
Termin
03. Jul 2017 - 06. Jul 2017
Ort
Rom, Italien
Zusammenfassung
The maintenance of genome integrity is critical for the suppression of cancer and premature ageing. Only recently has it become appreciated that DNA replication stress is a crucial driver of genomic instability. The timely progression of replisomes can be disrupted by lesions and secondary structures in the template, by bound proteins and by conflicts with the transcription machinery. A prolonged pause of the replisome then exposes single stranded DNA, which, due to its recombinogenic nature, can lead to genome rearrangements, fragile site expression and cell death. Importantly, some cancers present excessive endogenous levels of replication stress, which can be exploited for their clearance. In this conference, we aim to bring together scientists studying DNA replication and repair, with those interested in how DNA damage can influence cancer and ageing.
Kontakt
Laura Trundle;     Email: laura@fusion-conferences.com
Themen
DNA Replication, DNA Damage, Cancer, Ageing
Verwandte Fachgebiete
57.
 
Lancet Summit: COPD and Lung Cancer
ID
848799
Termin
28. Jul 2017 - 29. Jul 2017
Ort
Perth, Australien
Kontakt
Marie-Claire Morley;     Email: m.morley@elsevier.com
Themen
This new Summit, organised by The Lancet Respiratory Medicine and The Lancet Oncology, will cover all of the main areas of debate for patients with COPD and lung cancer from prevention, diagnosis, treatment through to palliative care. It will also look at shared lessons from having a better understanding of the development and management of both diseases. Abstracts are invited by April 17, 2017 for presentation as posters to supplement the invited lectures on the following topics:  Prevention of COPD and lung cancer  Screening for COPD and lung cancer  Genetic insights into disease development  Disease management and current interventions  COPD and lung cancer: latest insights into treatment paradigms  Infectious complications in patient management  Latest advances in surgery and radiation  Post treatment and end of life care The conference will be of interest to clinicians, oncologists, researchers, nurses, policy makers, and public and global health advocates working in respiratory diseases and lung cancer.
Verwandte Fachgebiete
58.
 
ICAHO2017 — International Conference on Advances in Hematology and Oncology
ID
844258
Termin
12. Aug 2017 - 13. Aug 2017
Ort
Coeur d'Alene, Vereinigte Staaten
Zusammenfassung
The goal of 5th International Conference on Advances in Hematology and Oncology (ICAHO 2017) is to improve the care of hematology and oncology patients by updating the hematology and oncology care providers about the new developments in the field. This ICAHO 2017 conference also provides attendees with opportunities to interact and network with top experts in hematology and oncology. We will have educational and scientific sessions.
Kontakt
Tara Shah;     Tel.: [3605244696];     Email: support@binayfoundation.org
Themen
Cancer, Blood disease, Cancer research, Hematology, Oncology
Verwandte Fachgebiete
59.
 
ESMO 2017 Congress
ID
799938
Termin
08. Sep 2017 - 12. Sep 2017
Ort
Madrid, Spanien
Zusammenfassung
“Integrating science into oncology for a better patient outcome.” In an era of deep understanding of the molecular biology underlying the development of cancer, it is crucial that researchers and clinicians exchange knowledge. The ESMO 2017 Congress, in partnership with EACR, will bring oncology professionals together to facilitate interaction and bridge knowledge sharing between the laboratory and clinic. The aim of ESMO 2017 is to work together, aligning the objectives of researchers and clinicians, in order to provide more precise direction leading to better treatment options for cancer patients. The ESMO Congress is  the  most influential annual meeting for oncology professionals in Europe. We invite you to save the date.
60.
 
EUS ENDO — EUS ENDO International Live Course
ID
850651
Termin
28. Sep 2017 - 29. Sep 2017
Ort
Marseille, Frankreich
Zusammenfassung
EUS-ENDO will offer one day of live transmission from Paoli-Calmettes Institute to the Villa Méditerranée in the new center of Marseille. We have invited worldwide experts on EUS and Endoscopy, they will give lectures and will demonstrate the last developments of these technologies (ERCP, ESD, Therapeutic EUS, etc….) during the live demonstrations. New scopes will be showed as new accessories. The main goal of this meeting will be to demonstrate the complementarity of EUS and ERCP for bilio-pancreatic diseases, to show also new procedures as radiofrequency ablation of bilio-pancreatic cancers, cholangio-pancreatoscopy, confocal laser endomicrsocopy, etc…

The second day will be dedicated to hands on, 6 stations will be available for ERCP, EUS-FNA, T.EUS, GI bleeding management, EMR &ESD. This second day should be interactive between the participants and the experts, 4 workshops will be organized and also 3 sessions of oral communications in which participants will debate with the experts. Abstracts presented during EUS-ENDO will be published in Endoscopic Ultrasound review.

Kontakt
Sylvie Martel;     Tel.: [+33 7 79 69 67 68];     Email: sylvie.martel@mcocongres.com
Themen
endoscopy, bilio-pancreatic diseases, cholangio-pancreatocopy, confocal laser endomicroscopy,
Verwandte Fachgebiete
61.
 
7th InterAmerican Oncology Conference
ID
814112
Termin
05. Okt 2017 - 06. Okt 2017
Ort
Buenos Aires, Argentinien
Zusammenfassung
The 7th. InterAmerican Oncology Conference "Current Status and Future of Anti-Cancer Targeted Therapies" will be held in Buenos Aires, Argentina in October 5th and 6th, 2017.

An outstanding faculty of speakers from the United States and Europe has committed in this meeting.

The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development.

Kontakt
Email: oncology@oncologyconferences.com.ar
Themen
New Anticancer Therapies, Novel Agents in Early Clinical Trials, Melanoma, Breast Cancer, Immunotherapies, Biomarkers for Checkpoint Inhibitors, Genitourinary Cancer, Prostate cancer, Metastatic Renal Cell Carcinoma, Bladder Cancer, Gastrointestinal Cancer, Gastric Cancer, Colorectal cancer, Lung cancer, Mesothelioma, Hematological Malignancies, Leukemia, Multiple Myeloma, Lymphoma
Verwandte Fachgebiete
62.
 
MAP : MOLECULAR ANALYSIS FOR PERSONALISED THERAPY
ID
841144
Termin
13. Okt 2017 - 14. Okt 2017
Ort
Zürich, Schweiz
Zusammenfassung
A joint initiative of Cancer Research UK, UNICANCER and ESMO, this conference shines a light on the latest medical developments on molecular analysis for personalised therapy.
Kontakt
Patrick Wahby;     Email: map@overcome.eu
Themen
Cancer, cancer research UK, unicancer, esmo, molecular analysis, personalised therapy, genome, oncology, metastatic, clinical oncologists, scientific.
63.
 
TBCC9 — The International Tehran Breast Cancer Congress
ID
830791
Termin
18. Okt 2017 - 20. Okt 2017
Ort
TEHRAN, Iran
Zusammenfassung
The International Tehran Breast Cancer Congress (ITBCC) provides a unique multidisciplinary setting for all professionals with a common interest in breast cancer to navigate, discuss, inform and educate themselves about this evolving disease landscape; to debate and deliberate about new data and developments; and to establish what it means for patient treatment and care.

Leading international and national scientists and physicians will address recent advances in breast cancer research, personalized therapy, and the latest clinical data impacting the treatment of breast cancer. Cutting-edge lectures, panel discussions, and interactive question-and-answer sessions will provide a unique opportunity for participants to engage with pioneers as they share their perspectives and personal experiences on the challenges and ongoing controversies in breast cancer.T

Kontakt
Secretariat;     Tel.: [+9821-88673129];     Email: CONGRESS@IBCRC.IR
Themen
New concepts in Breast Cancer ; ( Epidemiology, Oncoplatic surgery & reconstruction, Screening & Prevention, Neoadjuvant & Adjuvant therapy, Radiotherapy, Imaging, Genetics & Heredity, Immunotherapy & Cell Therapy, Pathology, Quality of life, Ethical aspects, Medical informatics, Fertility preservation & Tissue engineering)
Verwandte Fachgebiete
64.
 
Joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma Research
ID
764468
Termin
18. Okt 2017 - 21. Okt 2017
Ort
Brisbane, Australien
Kontakt
Vivien Lietze;     Tel.: [+4930204590];     Email: congress@worldmelanoma2017.com
Themen
Dermatology, Dermato-Oncology, Skin-Cancer, Melanoma
Verwandte Fachgebiete
65.
 
ESGO 2017 Congress in Vienna — 20th Biennial International Meeting of the European Society of Gynaecological Oncology
ID
825977
Termin
04. Nov 2017 - 07. Nov 2017
Ort
Wien, Österreich
Zusammenfassung
Held biennially, ESGO congress offers professionals in Gynaecological Oncology - including clinicians, researchers, residents and students a unique opportunity to learn and discuss the latest medical and scientific developments in gynaecological cancers research, treatment and care, as well as to network with key opinion leaders and peers from around the world.
Kontakt
Lucie Lamlova;     Email: lucie.lamlova@esgomail.org
Themen
the latest medical and scientific development, gynaecological cancers research, treatment and care
Verwandte Fachgebiete
66.
 
EMBL Conference: Cancer Genomics
ID
834578
Termin
05. Nov 2017 - 08. Nov 2017
Ort
Heidelberg, Deutschland
Zusammenfassung
This conference will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. It will cover presentations from cancer genome projects, the areas of cancer functional genomics, systems biology, cancer mouse models and the translation and clinical impact of scientific results obtained. The meeting will bring together leading scientists from across these areas for a unique opportunity to interact and stimulate further integration of these efforts.

European Cancer Genomics research is particularly strong in the Heidelberg area, with three International Cancer Genome Consortium (www.icgc.org) projects being currently pursued with significant participation from Heidelberg institutions, including EMBL. As in our 2015 meeting, a large number of renowned speakers will be invited, with a strong representation of overseas speakers. The atmosphere at the conference will make this an exceptional event with cutting edge science, extensive scientific discussions and ample possibilities for meetings between and after sessions to facilitate in-depth discussions and new collaborations.

Kontakt
Tel.: [4962213878797];     Email: marketing@embl.de
Verwandte Fachgebiete
67.
 
ICC2017 — 2nd Indian Cancer Congress
ID
833906
Termin
08. Nov 2017 - 12. Nov 2017
Ort
BANGALORE, Indien
Zusammenfassung
The Indian Cancer congress is an amalgamation of the four major national oncology associations ( The Association of Radiation Oncologists of India, Indian Association of Surgical Oncology, the Indian Society of Medical & Pediatric Oncologists and the Indian Society of Oncology) . This conference is a planned quadrennial event of these four associations and all other sub specialty associations to improve the quality of cancer care through multidisciplinary interactionand will be held in various parts of the Indian subcontinent once every four years. The ICC2017 conference is scheduled to be held from 9th to 12th November 2017 (with pre-conference workshop held on 8th Nov 2017) in Bengaluru, India.The theme for the conference is “INSIGHT, INNOVATION, INTEGRATION” The field of oncology is rapidly evolving and is in constant flux. What is thought to be true today may very soon be turned on its head by new insights and new innovations. It is therefore prudent and necessary that we the oncology community – periodically stop in our fast tracks and take stock of some important insights and innovations and debate how best we can integrate these innovations into our practice. The congress hopes to attract each and everyone involved in the care of the cancer patient including physicians, basic scientists, patients, survivors , care givers, researchers, investors etc and to provide a platform from which meaningful value addition can emerge.
Kontakt
Nalini Rao;     Tel.: [9845517681];     Email: nkrao@hotmail.com
68.
 
Cancer Imaging and Therapy
ID
836428
Termin
02. Apr 2018 - 06. Apr 2018
Ort
Hollywood, Vereinigte Staaten
Zusammenfassung
The Cancer Imaging and Therapy conference will focus on optical methods in cancer, centered on imaging and treatment of cancer. The conference will accept submissions on topics on the molecular and cellular level, such as reporters and theranostics; on the tissue and pre-clinical (animal) level, such as pathology methods and advances in imaging of tumor models; and on human tissue and living human subjects, when specifically dealing with cancer. More generic biomedical optics and biophotonics research involving human tissues or living human subjects should be submitted to the Clinical and Translational Biophotonics conference at this congress.

Interessant...

Ihr Banner-Ad könnte an dieser Stelle erscheinen!

Stand vom 01. Dezember 2016